Bills
H.R.7667

H.R.7667: Food and Drug Amendments of 2022

Read the bill

About This Bill

This bill was introduced in the 117th Congress
This bill is primarily about health
Introduced May 6, 2022
Latest Major Action June 9, 2022
See the one similar bills introduced in other congresses.

Bill Sponsor

Anna G. Eshoo (D-Calif.)

Bill Cosponsors

3 (1 Democrat, 2 Republicans)

Bill Versions

Engrossed in House - June 8, 2022
Reported in House - June 7, 2022
Introduced in House - May 6, 2022

Bill Summary

Food and Drug Amendments of 2022 This bill reauthorizes Food and Drug Administration (FDA) user fee programs for certain drugs and devices, establishes requirements to increase diversity in clinical trials, and modifies requirements relating to the overall supply chain for drugs and devices. Specifically, the bill reauthorizes through FY2027 the FDA user fee programs for prescription drugs, medical devices, generic drugs, and biosimilars. The...

(Source: Library of Congress)

What Lawmakers Are Saying About This Bill

There are 9 statements associated with H.R.7667.

See statements

Bill Actions

Date	Description
June 9, 2022	Received in the Senate.
June 8, 2022	On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 392 - 28 (Roll no. 254).
June 8, 2022	Considered as unfinished business.
June 8, 2022	On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 392 - 28 (Roll no. 254). (text: 06/07/2022 CR H5298-5319)
June 8, 2022	Considered as unfinished business. (consideration: CR H5402-5403)
June 8, 2022	Motion to reconsider laid on the table Agreed to without objection.
June 7, 2022	Considered under suspension of the rules. (consideration: CR H5298-5321; text: CR H5298-5319)
June 7, 2022	Considered under suspension of the rules. (consideration: CR H5298-5321)
June 7, 2022	At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.
June 7, 2022	DEBATE - The House proceeded with forty minutes of debate on H.R. 7667.
June 7, 2022	Mr. Pallone moved to suspend the rules and pass the bill, as amended.
June 7, 2022	Placed on the Union Calendar, Calendar No. 262.
June 7, 2022	Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 117-348.
May 18, 2022	Ordered to be Reported (Amended) by the Yeas and Nays: 55 - 0.
May 18, 2022	Committee Consideration and Mark-up Session Held.
May 11, 2022	Forwarded by Subcommittee to Full Committee (Amended) by the Yeas and Nays: 30 - 0 .
May 11, 2022	Subcommittee Consideration and Mark-up Session Held.
May 9, 2022	Referred to the Subcommittee on Health.
May 6, 2022	Referred to the House Committee on Energy and Commerce.
May 6, 2022	Introduced in the House by Anna G. Eshoo (D-Calif.)

Legislators

Bills

Statements

Lobbying

Travel